Features of neurodegeneration (N) have long been studied in the context of AD and indeed in vivo methods such as structural imaging long precede the development of neuroimaging techniques that are sensitive to pathologic amyloid and tau. The gene discussed is MAPT; the disease is Alzheimer disease.